← Back to headlines
Zai Lab Limited Gains EMA Orphan Drug Designation for Cancer Therapy
Zai Lab Limited (ZLAB) has received Orphan Drug Designation from the European Medicines Agency (EMA) for its DLL3-targeting cancer therapy.
30 Jun, 13:07 — 30 Jun, 13:07
Sources
Showing 1 of 1 sources
Related Stories
Germany Blames Russia for Leipzig Airport Drone Attack
18m ago
Japanese Police Arrest Man Over Killing of Dozens of Hamsters in Love Hotel
29m ago
Jury Deadlocks in Lindsay Clancy Triple-Murder Trial as Deliberations Continue
35m ago
Woman Killed and Suspect Shot Dead in Times Square Stabbing Attack
38m ago